Streetbeat News

Products Services

BRTX

BioRestorative Therapies (BRTX) announced that no dose limiting toxicity (DLT) was observed in the safety run-in segment of their study.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:38 am

BRTX

BioRestorative Therapies' Data Monitoring Committee has allowed the company's Chronic Lumbar Disc Disease study to continue unchanged.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:37 am

EGAN

eGain has introduced a unique pilot program for generative AI, allowing businesses to test the AI and knowledge capabilities for two weeks in a production setting without any cost, commitment, or catch.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:34 am

ACIU

AC Immune has been granted U.S. Patent #11684625 for compounds related to the treatment, alleviation, or prevention of disorders associated with tau aggregates.

Portfolio Pulse from Charles Gross

June 27, 2023 | 10:34 am

BDSX

Biodesix has completed enrollment of 5,000 non-small cell lung cancer patients in its INSIGHT study to further validate the utility of the VeriStrat test, a prognostic blood-based host immune classifier.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:16 am

SOL

Emeren Group has signed a Development Service Agreement (DSA) with Matrix Renewables to develop up to 1.5 GW of Battery Energy Storage Systems (BESS) in Italy. The first portfolio includes over 260 MW of standalone BESS projects.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:05 am

SOL

Emeren Group Ltd (NYSE:SOL) has partnered with Matrix Renewables to develop up to 1.5 GW of Battery Energy Storage Systems (BESS) in Italy. The first portfolio includes over 260 MW of standalone BESS projects.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 10:04 am

AMGN

LLY

NVO

The race to develop weight-loss drugs more potent than Ozempic and Mounjaro is heating up, with several contenders on the horizon. Novo Nordisk's Ozempic and Eli Lilly's Mounjaro have seen a surge in demand, and researchers are now focusing on next-generation weight-loss drugs. The success of these drugs has attracted new players like Amgen and Boehringer Ingelheim.

Portfolio Pulse from Benzinga Newsbot

June 27, 2023 | 9:49 am

IMMX

Immatics Biotechnologies has been granted U.S. Patent #11685769 for peptides used in immunotherapy against cancers. This patent could potentially strengthen the company's position in the cancer immunotherapy market.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:39 am

TSLA

Tesla has been granted U.S. Patent #11685293 for an electronically controlled seat system with tilt-and-slide mode, which could enhance user experience and comfort in their vehicles.

Portfolio Pulse from Charles Gross

June 27, 2023 | 9:28 am